The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Improving the translation of analgesic drugs to the clinic: animal models of neuropathic pain
Open accessAbstract
Neuropathic pain remains an area of considerable unmet clinical need. Research based on preclinical animal models has failed to deliver truly novel treatment options, questioning the predictive value of these models. This review addresses the shortcomings of rodent in vivo models commonly used in the field and highlights approaches which could increase their predictivity, including more clinically relevant assays, outcome measures and animal characteristics. The methodological quality of animal studies also needs to be improved. Low internal validity and incomplete reporting lead to a waste of valuable research resources and animal lives, and ultimately prevent an objective assessment of the true predictivity of in vivo models.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research
Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M., & Altman, D. G. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000412 · Cited by 7,300
Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research
Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M., & Altman, D. G. (2010) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.72351 · Cited by 6,277
Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
Animal research: Reporting in vivo experiments: The ARRIVE guidelines
Kilkenny, C., Browne, W., Cuthill, I. C., Emerson, M., & Altman, D. G. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00872.x · Cited by 3,625
Dworkin, R. H., Turk, D. C., Wyrwich, K. W., Beaton, D., Cleeland, C. S., Farrar, J. T., Haythornthwaite, J. A., Jensen, M. P., Kerns, R. D., Ader, D. N., et al. (2008) · The Journal of Pain · doi:10.1016/j.jpain.2007.09.005 · Cited by 3,471 · cited 2×
“In clinical trials, a broad range of measures and signs are usually measured as secondary outcomes and the IMMPACT group has provided recommendation on the domains that should be assessed (Dworkin et al., 2008).”
BackgroundMethodPharmacologic management of neuropathic pain: Evidence-based recommendations
Dworkin, R. H., O’Connor, A. B., Backonja, M., Farrar, J. T., Finnerup, N. B., Jensen, T. S., Kalso, E. A., Loeser, J. D., Miaskowski, C., Nurmikko, T. J., et al. (2007) · Pain · doi:10.1016/j.pain.2007.08.033 · Cited by 2,126 · cited 3×
“It is also difficult to predict treatment responses at the individual patient level (Dworkin et al., 2007; Finnerup et al., 2010).”
BackgroundNeuropathic pain: diagnosis, pathophysiological mechanisms, and treatment
Baron, R., Binder, A., & Wasner, G. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70143-5 · Cited by 1,816
Sex differences in pain and pain inhibition: multiple explanations of a controversial phenomenon
Mogil, J. S. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3360 · Cited by 1,065
Kilkenny, C., Parsons, N., Kadyszewski, E., Festing, M. F. W., Cuthill, I. C., Fry, D., Hutton, J., & Altman, D. G. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007824 · Cited by 860
Publication bias in reports of animal stroke studies leads to major overstatement of efficacy
Sena, E. S., van der Worp, H. B., Bath, P. M. W., Howells, D. W., & Macleod, M. R. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000344 · Cited by 600 · cited 2×
“In animal research, a study investigating publication bias in the field of stroke estimated that in addition to the 1359 experiments identified, a further 214 experiments (16%) yielding negative results had been carried out but not reported; publication bias accounted for around onethird of the efficacy reported in sy…”
BackgroundDrug discovery in pharmaceutical industry: productivity challenges and trends
Khanna, I. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.05.007 · Cited by 479 · cited 1×
“There is nothing to suggest that attrition has improved over the last decade as a success rate of 6% was observed in 2009–2010 (Khanna, 2012).”
BackgroundA painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel
Polomano, R. C., Mannes, A. J., Clark, U. S., & Bennett, G. J. (2001) · Pain · doi:10.1016/s0304-3959(01)00363-3 · Cited by 476
Good Laboratory Practice: Preventing Introduction of Bias at the Bench
Macleod, M. R., Fisher, M., O'Collins, V., Sena, E. S., Dirnagl, U., Bath, P. M. W., Buchan, A., van der Worp, H. B., Traystman, R., Minematsu, K., et al. (2009) · Stroke · doi:10.1161/strokeaha.108.525386 · Cited by 331
Macleod, M. R., van der Worp, H. B., Sena, E. S., Howells, D. W., Dirnagl, U., & Donnan, G. A. (2008) · Stroke · doi:10.1161/strokeaha.108.515957 · Cited by 319
Evaluation of excess significance bias in animal studies of neurological diseases
Tsilidis, K. K., Panagiotou, O. A., Sena, E. S., Aretouli, E., Evangelou, E., Howells, D. W., Salman, R. A.-S., Macleod, M. R., & Ioannidis, J. P. A. (2013) · PLoS Biology · doi:10.1371/journal.pbio.1001609 · Cited by 295 · cited 1×
“Additionally, an analysis of animal studies of neurological diseases, including over 4000 datasets, showed that there are too many animal studies with statistically significant results, which suggests strong selective analysis and outcome reporting biases (Tsilidis et al., 2013).”
BackgroundEmergency medicine animal research: does use of randomization and blinding affect the results?
Bebarta, V., Luyten, D., & Heard, K. (2003) · Academic Emergency Medicine · doi:10.1111/j.1553-2712.2003.tb00056.x · Cited by 244
Characterization of rodent models of HIV-gp120 and anti-retroviral-associated neuropathic pain
Wallace, V. C. J., Blackbeard, J., Segerdahl, A. R., Hasnie, F., Pheby, T., McMahon, S. B., & Rice, A. S. C. (2007) · Brain · doi:10.1093/brain/awm195 · Cited by 176
Self-citationDescription of a short-term Taxol®-induced nociceptive neuropathy in rats
Authier, N., Gillet, J.-P., Fialip, J., Eschalier, A., & Coudore, F. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02910-3 · Cited by 171
Hasnie, F. S., Breuer, J., Parker, S., Wallace, V., Blackbeard, J., Lever, I., Kinchington, P. R., Dickenson, A. H., Pheby, T., & Rice, A. S. C. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.11.029 · Cited by 144
Hu, B., Doods, H., Treede, R.-D., & Ceci, A. (2009) · Pain · doi:10.1016/j.pain.2009.02.018 · Cited by 138
Whole animal experiments should be more like human randomized controlled trials
Muhlhausler, B. S., Bloomfield, F. H., & Gillman, M. W. (2013) · PLoS Biology · doi:10.1371/journal.pbio.1001481 · Cited by 105
Assessing symptom profiles in neuropathic pain clinical trials: can it improve outcome?
Attal, N., Bouhassira, D., Baron, R., Dostrovsky, J., Dworkin, R. H., Finnerup, N., Gourlay, G., Haanpaa, M., Raja, S., Rice, A. S. C., et al. (2011) · European Journal of Pain · doi:10.1016/j.ejpain.2011.03.005 · Cited by 105
Self-citationWallace, V. C. J., Segerdahl, A. R., Lambert, D. M., Vandevoorde, S., Blackbeard, J., Pheby, T., Hasnie, F., & Rice, A. S. C. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707326 · Cited by 66 · cited 3×
“…2009; Polomano et al., 2001; Flatters and Bennett, 2004; Ling et al., 2007; Zheng et al., 2011) or anti-retroviral therapy (Joseph et al., 2004; Wallace et al., 2007b; Huang et al., 2013), diabetic neuropathy (Malcangio and Tomlinson, 1998; D’Almeida et al., 1999), multiple sclerosis (Aicher…”
BackgroundSelf-citationRice, A. S. C., Morland, R., Huang, W., Currie, G. L., Sena, E. S., & Macleod, M. R. (2013) · Scandinavian Journal of Pain · doi:10.1016/j.sjpain.2013.02.002 · Cited by 42 · cited 4×
“Many have raised concerns about the underreporting of crucial aspects of the design and conduct of animal studies in general (Kilkenny et al., 2009; Muhlhausler et al., 2013) and in the field of pain specifically (Rice et al., 2009; 2013; Mogil et al., 2010a).”
BackgroundInfluentialSelf-citationAssay sensitivity and study features in neuropathic pain trials: An ACTTION meta-analysis
Dworkin, R. H., Turk, D. C., Peirce-Sandner, S., He, H., McDermott, M. P., Farrar, J. T., Katz, N. P., Lin, A. H., Rappaport, B. A., & Rowbotham, M. C. (2013) · Neurology · doi:10.1212/wnl.0b013e318297ee69 · Cited by 38 · cited 1×
“Furthermore, the design, conduct and analysis of phase 2 and 3 trials in neuropathic pain is not perfect and are being carefully scrutinized as an element of translational failure (see http:// www.acttion.org and http://www.immpact.org; for examples see Dworkin et al., 2008; 2010b; 2013).”
MethodRobinson, I., Dowdall, T., & Meert, T. F. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.06.078 · Cited by 22
Cited by
Assessment and manifestation of central sensitisation across different chronic pain conditions
Arendt‐Nielsen, L., Morlion, B., Perrot, S., Dahan, A., Dickenson, A., Kress, H. G., Wells, C., Bouhassira, D., & Drewes, A. M. (2018) · European Journal of Pain · doi:10.1002/ejp.1140 · Cited by 695
Cannabinoids, the endocannabinoid system, and pain: a review of preclinical studies
Finn, D. P., Haroutounian, S., Hohmann, A. G., Krane, E., Soliman, N., & Rice, A. S. C. (2021) · Pain · doi:10.1097/j.pain.0000000000002268 · Cited by 254
Self-citationAmbroxol for neuropathic pain: hiding in plain sight?
Russo, M. A., Baron, R., Dickenson, A. H., Kern, K.-U., & Santarelli, D. M. (2023) · Pain · doi:10.1097/j.pain.0000000000002693 · Cited by 20
Metadata
- Authors
- Percie du Sert, N., & Rice, A. S. C.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2014-05-27
- Volume
- 171
- Issue
- 12
- Pages
- 2951-2963
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1539841279
- Cited by
- 188
- References
- 26
- FWCI
- 11.27
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.